close

Agreements

Date: 2011-10-28

Type of information: Commercialisation agreement

Compound: protein analytics from detailed protein characterization to stability and lot release testing

Company: Protagen (Germany) Charles River (USA)

Therapeutic area:

Type agreement:

commercialisation

Action mechanism:

Disease:

Details:

Protagen, a GMPcertified specialist in the characterization of protein drugs and Charles River Laboratories International, Inc., one of the world leading companies in highquality research models and preclinical and clinical support services, have announced a strategic Marketing & Sales alliance.For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles River BPS delivers client-focused solutions tailored to the specific testing and manufacturing requirements of biologics. Partnering with Protagen AG, an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis, will provide clients with services covering the entire range of protein analytics from detailed protein characterization to stability and lot release testing. Working together, Charles River and Protagen can offer analytical experience and superior services through a single point of contact, providing more efficient project work and study design.

Financial terms:

Latest news:

Is general: Yes